SC 13G Filing

Company

RIGEL PHARMACEUTICALS INC

Filed

November 14, 2019

Accession Number

0001319244-19-000084

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →